Peter Libby, MD
Lawrence A. Leiter, MD
Prof. Kausik Ray, MBChB, MD, MPhil
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASCVD Risk Reduction
Panel Discussion on AHA Symposium: Clinical Rundown—3 Hot Topic Sessions on ASC…
Robert J. Chilton, DO
John R. Nelson, MD, FACC, FNLA, FASNC
Clinicians' Update on Omega-3s in ASCVD Risk Reduction
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
Leslie Cho, MD
Clinician’s Update on Omega-3s in ASCVD Risk Reduction
Michael Miller, MD, FACC, FAHA, FNLA
Brian Olshansky, MD, FACCP, FAHA, FHRS, FESC
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid Clinical Trials and EPA/DHA
Understanding the Differences Between STRENGTH and REDUCE-IT Omega-3 Fatty Acid…
